[1] 徐飚,王建明.胃癌流行病学研究[J].中华肿瘤防治杂志,2006(1):81-87.
[2] KATIYAR S K,MUKHTAR H.Tea in chemoprevention of cancer;epi-demiologic amd experimental studies[J].Intl J Oncol,1996,8:221-238.
[3] 张艳艳,韩婷,吴令上,等.三尖杉碱类化合物的来源、药理作用及临床应用研究进展[J].现代药物与临床,2011(5):370-374.
[4] 李玉峰,丁帮和,朱家斌,等.伊马替尼联合高三尖杉酯碱治疗初诊慢性髓细胞性白血病疗效观察[J].东南大学学报:医学版,2009,28(5):430-432.
[5] LI Y F,LIU X,LIU D S.The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy[J].Leuk Lymphoma,2009,50(11):1889-1891.
[6] HA T K,JUNG M S,LEE K H.The effect of adjuvant chemotherapy on stage Ⅳ(T4N1-3M0 and T1-3N3M0) gastric cancer[J].Cancer Res Treat,2009,41(1):19-23.
[7] 何洪源.中国粗榧果实和枝叶中三尖杉酯碱和高三尖杉酯碱分离方法的研究[J].中草药,2001(3):11-2.
[8] XU W L,JIN J,QIAN W B.Homoharringtonine in combination with cytarabine and aclarubicin as induction therapy improves remission and survival of patients with higher risk myelodysplastic syndromes[J].Chin Med J,2010,123(1):108-110.
[9] GU L F,ZHANG W G,WANG F X,et al.Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia[J].J Cancer Res Clin Oncol,2011,137(6):997-1003.
[10] JIN Y,LU Z,CAO K,et al.The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation[J].Mol Cancer Ther,2010,9(1):21-23.
[11] CHEN R,GUO L,CHEN Y,et al.Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia[J].Blood,2011,117(1):156-64. |